Celularity Inc. has secured a $1,000,000 secured loan from the Philip & Daniele Barach Family Trust, a trust affiliated with a beneficial owner of over five percent of the company's Class A common stock. The loan carries an annual interest rate of 4.0%, which can increase to 18.0% upon an event of default. The loan matures 30 days after closing or upon the company's receipt of gross proceeds from certain financing or strategic transactions. The loan is secured by a first-priority security interest in substantially all of the company's personal property, subject to existing liens. As a condition for funding, Robert J. Hariri, M.D. entered into a waiver and subordination agreement regarding indebtedness owed to him by the company. Vincent LeVien resigned from the company's Board of Directors, effective June 26, 2026, with no stated disagreement with the company's operations, policies, or practices.